SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000217028-03-000002
Filing Date
2003-09-17
Accepted
2003-09-17 15:53:55
Documents
1
Period of Report
2003-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4975
  Complete submission text file 0000217028-03-000002.txt   7132
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
AVENTIS INC (Reporting) CIK: 0000217028 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 03899609
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Issuer) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations